High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis | Zendy

Howard N. Hodis | Zendy; Wendy J. Mack | Zendy; Laurie Dustin | Zendy; Peter R. Mahrer | Zendy; Stanley P. Azen | Zendy; Robert Detrano | Zendy; Jacob Selhub | Zendy; Petar Alaupovic | Zendy; Chaoran Liu | Zendy; Liu Ci-hua | Zendy; Juliana Hwang | Zendy; Alison Wilcox | Zendy; Robert H. Selzer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

High-Dose B Vitamin Supplementation and Progression of Subclinical Atherosclerosis

Author(s) -

Howard N. Hodis,

Wendy J. Mack,

Laurie Dustin,

Peter R. Mahrer,

Stanley P. Azen,

Robert Detrano,

Jacob Selhub,

Petar Alaupovic,

Chaoran Liu,

Liu Ci-hua,

Juliana Hwang,

Alison Wilcox,

Robert H. Selzer

Publication year - 2009

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.108.526798

Subject(s) - medicine , homocysteine , placebo , subclinical infection , vitamin d and neurology , gastroenterology , intima media thickness , coronary artery disease , cardiology , vascular disease , vitamin , b vitamins , endocrinology , pathology , carotid arteries , alternative medicine

Although plasma total homocysteine (tHcy) levels are associated with cardiovascular disease, it remains unclear whether homocysteine is a cause or a marker of atherosclerotic vascular disease. We determined whether reduction of tHcy levels with B vitamin supplementation reduces subclinical atherosclerosis progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research